Conference Agenda 2024

  • 08:15
  • Registration & Refreshments

    Kick off your conference experience by checking in at our registration desk. Collect your event materials and enjoy a selection of refreshments. It's the perfect time to mingle with fellow attendees and set the tone for an engaging and informative event

  • 08:50
  • Welcome Address & Chairperson’s opening remarks

    Begin your conference journey with a warm welcome from our esteemed Chairperson

    Bruce Hellman

    Bruce Hellman Co-Founder & Chief Patient Officer

Digital Innovation & Transformation in Pharma

  • 09:00
  • Digital Transformation: Developing and deploying a digital authoring platform across the value chain

    • Use of AI in clinical document development
    • Taking a holistic approach, expanding beyond clinical documentation
    • Deployment strategy, making digital tools operational
    • Value generation today and in the future, speeding up submission file creation

    Louise Lind Skov

    Louise Lind Skov Head of Content Digitalisation
    Novo Nordisk

    Waheed Jowiya

    Waheed Jowiya Digitalisation Strategy Lead
    Novo Nordisk

  • 09:30
  • Can drug repurposing be saved with artificial intelligence?

    Paul Agapow

    Paul Agapow Director

  • 10:00
  • Beyond the molecule: when software understands the patient

    Gary Crawford

    Gary Crawford Chief Innovation Officer

  • 10:40
  • Business Card Exchange with Morning Coffee/Tea & Discussion

    Network over morning coffee or tea, exchanging business cards or using our app's QR code scanner for easy contact sharing. A prime moment for engaging discussions and new connections



  • 11:00
  • Collaborative Innovation: Finding the right partners to leverage new technologies in Pharma

    • How early-stage partnering and collaboration will inhibit pharma innovation
    • How Biotech revolution has changed the face of drug development?
    • Working with incubators, accelerators and innovation forums can also help
    • Having a good governance structure in place

    Konrad Dobschuetz

    Konrad Dobschuetz Global HealthTech Leader
    former National Director NHS Innovation Accelerator

  • 11:30
  • Implementation and Relevance of FAIR Data Principles in Big Pharma

    • Improving the efficiency and effectiveness by implementing the FAIR guiding principles for scientific data
    • Tools enabling FAIR data
    • Fair as a machine learning enabler
    • Benefits of FAIR in pharma

    Jimmy Toulas

    Jimmy Toulas Real World and Commercial Data Director, EMEA & China

  • 12:00
  • Network models in drug discovery and development

    Julio Molineros

    Julio Molineros Associate Director
    Johnson & Johnson Innovative Medicine

  • 12:30
  • Luncheon & Networking - Explore, Engage with Your Peers, and Connect at Our Exhibitor Booths

    Enjoy a luncheon while networking with peers and exploring exhibitor booths. This is an ideal time to engage with industry leaders, delve into innovative solutions, and forge valuable connections in a collaborative atmosphere.



  • 13:25
  • The evolving patent landscape at the intersection of biotechnology and AI

    Luke Tregilgas

    Luke Tregilgas Patent Attorney
    Haley Guiliano

  • 13:50
  • Case Study – How Novo Nordisk leverage in silico tools like AI/ML and genetics to reach strategic priorities

    Jakob E. Larsen

    Jakob E. Larsen Target Discovery Engine Project Director
    Novo Nordisk

  • 14:20
  • Essential innovations to unlock the potential of precision medicine

    Guillaume Desachy

    Guillaume Desachy Head of Biometrics
    Pierre Fabre

  • 14:45
  • The impact of AI in Biologics discovery and optimisation for Pharma

    Andrew Buchanan

    Andrew Buchanan Principal Scientist

  • 15:15
  • Recharge with Tea or Coffee While Networking

    Refresh with a tea or coffee break, using this time to continue networking. It's a perfect opportunity to discuss ideas, share experiences, and connect with fellow attendees in a relaxed setting.



  • 15:35
  • The Impact of Multi-omic Analysis/Integration in Diagnosing Disease and Driving Drug Development

    James Duboff

    James Duboff Strategic Partnerships Director
    Genomics England

  • 16:05
  • Connected data and single patient jackets for precision health

    Andy Cachaldora

    Andy Cachaldora General Manager Digital Service Northern Europe
    GE Healthcare

  • 16:35
  • Corporate start-up partnerships in digital health

    Dan Ma

    Dan Ma Head of Innovation & New Commercial Partnerships | Head Sandoz Innovation Lab Germany

    Benjamin Friedrich

    Benjamin Friedrich Chief Medical Officer & Co-Founder

  • 17:05
  • AI in Oncology: Personalizing Cancer Treatment and Care

    Rafik Fellague-Chebra

    Rafik Fellague-Chebra Executive Global Group medical Director
    Novartis Oncology

  • 17:30
  • Executives Discussion and Debate: Empowering drug discovery and development: the AI and Machine Learning revolution?

    • How pharmaceutical companies are adopting AI to discover new drugs and improve existing ones, and the impact this is having on their R&D strategies
    • How AI is not just a tool for research but is reshaping business models, leading to collaborations with tech companies, the rise of AI-driven biotech firms, and changes in investment strategies
    • Strategies to maximize AI & ML's impact in drug discovery and development
    • Mitigating risks and uncertainties in drug development through AI. Explore how AI is being used to navigate the complexities of both early-stage discovery and late-stage clinical trials

    Bruce Hellman

    Bruce Hellman Co-Founder & Chief Patient Officer

    Jakob E. Larsen

    Jakob E. Larsen Target Discovery Engine Project Director
    Novo Nordisk

    Julio Molineros

    Julio Molineros Associate Director
    Johnson & Johnson Innovative Medicine

    Marianna Esposito

    Marianna Esposito Business Development Director
    Intelligencia AI

    Victor Barzey

    Victor Barzey Product Lead, Digital Healthcare
    Otsuka Pharmaceutical Companies Europe

  • 18:00
  • Graph-in, graph-out: how graph Retrieval Augmented Generation (g-RAG) improves business value delivery out of Large Language Models

    Cedric Berger

    Cedric Berger Head of Knowledge Extraction and Integration

  • 18:30
  • Chair Person's Closing remarks

    End the conference with the Chairperson's closing remarks, summarizing key insights and leaving attendees with final thoughts to inspire ongoing engagement and action.

  • 18:40
  • Networking Drinks Session - Unwind with Evening Drinks and Engaging Conversations

    Wrap up the day with evening drinks and lively conversations. A relaxed setting to network, share insights from the day, and enjoy the company of fellow attendees.


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now